Pelican Acquisition Corporation Ordinary Shares
Pelican Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in technology industry. The company was incorporated in 2024 and is based in New York, New York.
Pelican Acquisition Corporation Ordinary Shares (PELI) - Net Assets
Latest net assets as of October 2025: $87.74 Million USD
Based on the latest financial reports, Pelican Acquisition Corporation Ordinary Shares (PELI) has net assets worth $87.74 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($88.05 Million) and total liabilities ($311.25K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $87.74 Million |
| % of Total Assets | 99.65% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Pelican Acquisition Corporation Ordinary Shares - Net Assets Trend (2025–2025)
This chart illustrates how Pelican Acquisition Corporation Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pelican Acquisition Corporation Ordinary Shares (2025–2025)
The table below shows the annual net assets of Pelican Acquisition Corporation Ordinary Shares from 2025 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-01-31 | $12.91K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pelican Acquisition Corporation Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Current Equity Component Breakdown (January 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $287.00 | 2.22% |
| Other Components | $24.71K | 191.41% |
| Total Equity | $12.91K | 100.00% |
Pelican Acquisition Corporation Ordinary Shares Competitors by Market Cap
The table below lists competitors of Pelican Acquisition Corporation Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Envela Corp
NYSE MKT:ELA
|
$81.26 Million |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
$81.27 Million |
|
Everybot Inc.
KQ:270660
|
$81.28 Million |
|
Keding Enterprises Co Ltd
TW:6655
|
$81.30 Million |
|
Indo Borax & Chemicals Limited
NSE:INDOBORAX
|
$81.23 Million |
|
DMS Co.Ltd
KQ:068790
|
$81.21 Million |
|
MedPacto Inc
KQ:235980
|
$81.20 Million |
|
Prospect Resources Ltd
AU:PSC
|
$81.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pelican Acquisition Corporation Ordinary Shares's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Pelican Acquisition Corporation Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8373.86x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2025-01-31 | $0.00 | $10.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pelican Acquisition Corporation Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -329.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 16.97x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2025 | -329.67% | 0.00% | 0.00x | 16.97x | $-43.86K |
Industry Comparison
This section compares Pelican Acquisition Corporation Ordinary Shares's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pelican Acquisition Corporation Ordinary Shares (PELI) | $87.74 Million | -329.67% | 0.00x | $81.24 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |